{"name":"Carisma Therapeutics Inc","slug":"carisma-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":59673000,"netIncome":-60477000,"cash":30458000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2017"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxNc1lsTmVGYmFzSGkzRXlVX2RMeDI2UlQ0VVJBVkhYMkQ1VlpaMFNCX3gtdzBwZEU5UWtUbWNPWmxhMm5jQ3AyMWtMMXhkVW9RSlM2bTNzVy1SdUt6Vmp0Wjk3T0tvUGZHQktEc1B0aTBBbUNfelU4XzFoOHZWVEdrVFpNYklZbFZNQWFDUlFhbVFaaDdYVE03VlNvdk9VczhYY2Q2Ul9KX0F3c3RKQk1QZVQxa3BuOEJOMnQ2Q1lwc3hLYkc5UEtSWm1wTVNHMVpaQ2Y1SmQ3dGljYS1aWjNIWVotRUI1T1lTLUZMb3ROenV5T2ZPOVl5cnVBV19CbTNabnRhOGQzSXhhY1pDWnBXOGFabw?oc=5","date":"2026-03-21","type":"trial","source":"Barchart.com","summary":"HER2 Positive Gastric Cancer Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com","headline":"HER2 Positive Gastric Cancer Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Ma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPWGFITUJlcVQxcW9jaE54MVplRllGaVozd0wxQldPZUZIaEVNdWVnNld3NWM3T1J5VlBFdWp5MThGbm9BSFNJanlYdllVX2xQbnNyRWhaVGpCZEJtVFJMeGhiZWJIZFdWd0EtRFNYdXh6MFFpZkJ2eDk3SFVSVk8xa3djLUhSS2lqbG5GNGVIZ0xIenVBVFd5RXZTY0ZUQjlDOUtacG5HUjNqWV8yZ1YydGlyR3RvbWRET19vcUdmWkoxSFdqLXV2c1NOSHFsZXdHT0wyX2JZWFdjTE1rNTBrZHpTV2FqaVE2N3c?oc=5","date":"2025-09-02","type":"regulatory","source":"Benzinga","summary":"Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket - Benzinga","headline":"Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQbTV2WDZrTHUzZlZaSnhxSWcwbzJXZFo1NHhJQU5hWkdIR3BDZ3pHbmU4cUx3TU5pNXpzaG15eDJsM1JsUks1anhqTFJ6Mk95TzVOaVRneTFEUWFCYzNJNDNoREV1YTQ3V0VUT0ZxY2lnT0JMVHNhZkk3Ui1pbHM4Wm1tUHhqa1QzOGowQTlYcUpzYjV1aUxKdWFtUQ?oc=5","date":"2025-06-24","type":"deal","source":"Yahoo Finance","summary":"Carisma Therapeutics, OrthoCellix enter definitive merger agreement - Yahoo Finance","headline":"Carisma Therapeutics, OrthoCellix enter definitive merger agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxNZGtWZHFNbTBHS1YyTU1ENWd4Y09VQ3ZPbWQ2NmZyUHlVbl8zdU5JR1hwbl9aN2xQdlNHaWNSdWV4cjlOdEhHMGVSeEtkaWlVOFN5dGRZZHRHLUN4b1dBUmFGNGVIcWhTTi1NTnNnb00yUDlkLXRzTWVtTFZyT1ozbUtGTmxlUnZzZmEwQkZXSEVIXzR1VkxDWlluLVRXR0tDdTZteTQ0V2ZFbGM3TmJjVWM1TEI4MUlHWnRCOEwydmx6YUtreVMybWJoUWxkSkZtb3dYb1VJNjVLSTdFNWotdGY1ZnlxdnNRWkt1Q2VCeGVvbVpfUWptOXlISkhNZ01FQWF3Zks5YWVJQ0FVYkVpV2x1TnVTdVpK?oc=5","date":"2025-06-09","type":"regulatory","source":"PR Newswire","summary":"HER2+ Gastric Cancer (including GEJ) Market to Increase at a Remarkable Growth Rate of 13% During the Study Period (2020-2034) | DelveInsight - PR Newswire","headline":"HER2+ Gastric Cancer (including GEJ) Market to Increase at a Remarkable Growth Rate of 13% During the Study Period (2020","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1LZVEwaUlpSHpzcUNFUTVnYjFZeUZIOVJGTDlKWGF2NVJxckI1Q0NOYUVpSlhtQTcySWVGZWxnVkltZkl4czdCek1lWWJOOFRyaXBB?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"CARM Stock Price, News & Analysis - Stock Titan","headline":"CARM Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxObnlTeFVEX0NLck5Vem5naXQySWd4aGpUNUNjd0E5T09mNGt4VEdtb2VWWGJJQ01WOXpWV1RTTlNWVlYyR2lGUmczcDNlWW0tQ3RkRW1fNXh3WUNFdWQ4QW1VZGFsLUxMdzlGSVZGUnM4SWgwOEVFUnpuVlZjclZ0M1gwa1pPdGJnZE43QTZMbUNhNjY3bkE?oc=5","date":"2025-04-01","type":"regulatory","source":"Fierce Biotech","summary":"Carisma winds down operations, lays off 95% of remaining staff - Fierce Biotech","headline":"Carisma winds down operations, lays off 95% of remaining staff","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPMGZ3Mlk1TVBQTkFDUmhKUGdOZ2F5U0o2Sy1aaXhFSllwc1BGc3RmTEFyb0tFb1B2MGxDbEw4NjFKYWxQdWl3X0hzUUNCNXRtdnMySjRDeVdYNWZIaXhoUjM0dS1hNGFjeWlhM1lPWGt5eHVpM2Z2WmZxVmcyWkk4TUw5cGotMW5QVWFscnRCT01OR01EeEdld0lYOUg?oc=5","date":"2025-04-01","type":"pipeline","source":"BioSpace","summary":"Carisma Lays Off Most of Staff, Eyes Sale of Assets and Company - BioSpace","headline":"Carisma Lays Off Most of Staff, Eyes Sale of Assets and Company","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-03-28","type":"pipeline","source":"simplywall.st","summary":"Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Business And Shares Still Trailing The Industry - simplywall.st","headline":"Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Business And Shares Still Trailing The Industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPV3VnQXRlczdKLWEwcGY0bHJJNExsRzltWV9SbGNWcS01b2NZaEM4M0ZpR19aOGxaX19OSG5zZDd2WllwSlhKblhlelVCNVpCd3V4dlp6UUh1RUpjTlZvZVRxd0FmQ3JqMVV6Y1F0SjVtcU5uMGN4Y3pYNHBNTVo0c2xaalVpMlU2VUExVHgweUdhSmlPUUdjckUyaW5mTEVBWEJsMVlJai1NcldwVUEwdUtDRFBqOW8?oc=5","date":"2025-01-10","type":"pipeline","source":"Investing.com","summary":"Carisma Therapeutics faces Nasdaq delisting over share price - Investing.com","headline":"Carisma Therapeutics faces Nasdaq delisting over share price","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOajM4OGxtU0x1UGtzWWpIc0xMRVFSR0djb1Vra1B5anl0Zzc4QjRYYWJkcmNQanIySWpTdUdfY1RMNC1XVXBBTXJUcmxEVkhMUWxIb2RLWWN1MDUxMmFJMzhOQVNCUUZiTjlfUFFsQ3VNblo1cG1xQUV2eUVEeUVkRmh3R3RSaDVSNWM5RUhLbDdNMHR0cTdqZ1JjTmdfcUh2QVpCMDhBNk1GZkJRSVlRZDVXVU5YZHhaeGlScGU4UjB0dEMxNUgyOWlwMWQyazlrb0E?oc=5","date":"2024-12-09","type":"pipeline","source":"PR Newswire","summary":"Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline - PR Newswire","headline":"Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQNGY4dXNMRERtWFhrbVl4c1hGa0MzbEtqR193WWlXWmVmZVlCaE1SZGQwdmQzek9XenY4MVZWUXZEUGNTQW9ZdFdhRGhPREtiNVZ3YkFodHVna1RUM0VTTnBncmFrbGw3blJJV1pjT29KUC1uT1hhSElTQ096Uy1VUjNMRHk0aTQ5T3pDSFgybmJUdTlYU1M3MWhqb1J5QjFYZmp6eGNRa1FaTDQxZHlTUnFR?oc=5","date":"2024-09-11","type":"deal","source":"Contract Pharma","summary":"Carisma, Moderna Expand CAR-M Collaboration for Autoimmune Diseases - Contract Pharma","headline":"Carisma, Moderna Expand CAR-M Collaboration for Autoimmune Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPcV9PTG5RSzJQaHFWT0FabjlmekhpNXViSEZ0YUZnMEhrRHBfZHppZTYxM19NaGV3NGVPdi1sU0NPblZiU3hTSHV3X1I1VDEzcjFIR3RWRGlWYUZ2R3k1SHFGZnA5cU9RQXNCU3JyTnZtZk1pTS1OOXNjMDBWV09QMGs1UGdZUFpfVDJ2bg?oc=5","date":"2022-09-21","type":"pipeline","source":"BioPharma Dive","summary":"Cell therapy startup Carisma merges with troubled Sesen in bid for Wall Street - BioPharma Dive","headline":"Cell therapy startup Carisma merges with troubled Sesen in bid for Wall Street","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2017-12-31","revenueHistory":[{"value":0,"period":"2017-12-31"},{"value":406000,"period":"2016-12-31"},{"value":406000,"period":"2016-12-31"},{"value":490000,"period":"2015-12-31"},{"value":490000,"period":"2015-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":59673000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-60477000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":30458000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}